Novel Aspects Targeting Platelets in Atherosclerotic Cardiovascular Disease-A Translational Perspective

Int J Mol Sci. 2023 Mar 27;24(7):6280. doi: 10.3390/ijms24076280.

Abstract

Platelets are important cellular targets in cardiovascular disease. Based on insights from basic science, translational approaches and clinical studies, a distinguished anti-platelet drug treatment regimen for cardiovascular patients could be established. Furthermore, platelets are increasingly considered as cells mediating effects "beyond thrombosis", including vascular inflammation, tissue remodeling and healing of vascular and tissue lesions. This review has its focus on the functions and interactions of platelets with potential translational and clinical relevance. The role of platelets for the development of atherosclerosis and therapeutic modalities for primary and secondary prevention of atherosclerotic disease are addressed. Furthermore, novel therapeutic options for inhibiting platelet function and the use of platelets in regenerative medicine are considered.

Keywords: atherosclerosis; coronary artery disease; ischemic stroke; myocardial infarction; neuroinflammation; neurovascular disease; platelets; thrombosis.

Publication types

  • Review

MeSH terms

  • Atherosclerosis* / drug therapy
  • Atherosclerosis* / pathology
  • Blood Platelets
  • Cardiovascular Diseases* / drug therapy
  • Humans
  • Myocardial Infarction* / drug therapy
  • Thrombosis* / drug therapy

Grants and funding

This work was supported by the Volkswagen Foundation (Lichtenberg program) to H.F.L. and the DZHK (German Research Centre for Cardiovascular Research), partner site Mannheim/Heidelberg to H.F.L., D.D. and H.F.L. was further supported by an ERA PerMed 2020 JTC grant “PROGRESS”. Moreover, H.F.L. and D.D. were supported by the SFB1366/2 (project B08) and the DZHK partner site Mannheim/Heidelberg.